Blueprint Medicines Income Statement

Financials in millions AUD. Fiscal year is July - June.

Millions AUD. Fiscal year is Jul - Jun.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '24 Dec 31, 2024	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Operating Revenue	387.35	342.21	259.04	171.79	119.53
Other Revenue	25.92	22.77	17.73	-	-
Revenue	413.26	364.99	276.77	171.79	119.53
Revenue Growth (YoY)	23.57%	31.87%	61.11%	43.72%	-
Cost of Revenue	268.87	241.31	184.15	44.19	31.8
Gross Profit	144.39	123.68	92.62	127.6	87.74
Selling, General & Admin	81.82	78.53	49	122.66	84.66
Other Operating Expenses	22.63	17.87	14	-4.4	-5.54
Operating Expenses	138.75	127.52	88.55	118.26	79.12
Operating Income	5.65	-3.85	4.07	9.33	8.61
Interest Expense	-15.82	-13.39	-8.2	-6.01	-5.16
Interest & Investment Income	13.94	4.84	3.63	3.17	2.94
Other Non Operating Income (Expenses)	0.94	0.84	0.66	-	-
EBT Excluding Unusual Items	4.71	-11.56	0.16	6.5	6.39
Gain (Loss) on Sale of Assets	-	-	-	0.06	-0.07
Other Unusual Items	-	-	-	0.06	-
Pretax Income	4.71	-11.56	0.16	6.61	6.32
Income Tax Expense	7.2	2.19	2.42	2.7	2.34
Net Income	-2.49	-13.75	-2.27	3.91	3.99
Net Income to Common	-2.49	-13.75	-2.27	3.91	3.99
Net Income Growth	-	-	-	-1.93%	-
Shares Outstanding (Basic)	94	86	84	82	-
Shares Outstanding (Diluted)	94	86	84	82	-
Shares Change (YoY)	10.64%	1.88%	2.20%	-	-
EPS (Basic)	-0.03	-0.16	-0.03	0.05	-
EPS (Diluted)	-0.03	-0.16	-0.03	0.05	-
Free Cash Flow	1.71	3.27	-4.77	0.25	11.4
Free Cash Flow Per Share	0.02	0.04	-0.06	0.00	-
Gross Margin	34.94%	33.88%	33.46%	74.28%	73.40%
Operating Margin	1.37%	-1.05%	1.47%	5.43%	7.21%
Profit Margin	-0.60%	-3.77%	-0.82%	2.28%	3.34%
Free Cash Flow Margin	0.41%	0.90%	-1.72%	0.15%	9.54%
EBITDA	21.72	12.05	15.2	17.14	13.55
EBITDA Margin	5.25%	3.30%	5.49%	9.98%	11.34%
D&A For EBITDA	16.07	15.9	11.14	7.8	4.94
EBIT	5.65	-3.85	4.07	9.33	8.61
EBIT Margin	1.37%	-1.05%	1.47%	5.43%	7.21%
Effective Tax Rate	152.81%	-	1553.20%	40.84%	36.94%

Updated Feb 20, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.